osi-906
Showing 1 - 12 of 12
Advanced Solid Tumors, Pharmacokinetics of 14C-OSI-906 Trial in Tacoma (radio-labeled OSI-906, OSI-906)
Completed
- Advanced Solid Tumors
- Pharmacokinetics of 14C-OSI-906
- radio-labeled OSI-906
- OSI-906
-
Tacoma, Washington
- +1 more
Feb 14, 2019
Advanced Solid Tumors Trial in Houston, Sutton (OSI-906)
Completed
- Advanced Solid Tumors
- OSI-906
-
Houston, Texas
- +1 more
Jan 29, 2019
Advanced Solid Tumors Trial in Nashville, Glasgow (OSI-906)
Completed
- Advanced Solid Tumors
- OSI-906
-
Nashville, Tennessee
- +1 more
Jan 10, 2019
NSCLC, Non Small Cell Lung Cancer Trial in Worldwide (OSI-906, Erlotinib, Placebo)
Completed
- NSCLC
- Non Small Cell Lung Cancer
- OSI-906
- +2 more
-
La Jolla, California
- +28 more
Jan 21, 2019
Adrenocortical Carcinoma Trial in Worldwide (OSI-906, Placebo)
Completed
- Adrenocortical Carcinoma
- OSI-906
- Placebo
-
Scottsdale, Arizona
- +34 more
Aug 31, 2018
Advanced Hepatocellular Carcinoma (HCC) Trial in Worldwide (OSI-906, Placebo)
Terminated
- Advanced Hepatocellular Carcinoma (HCC)
- OSI-906
- Placebo
-
Los Angeles, California
- +40 more
Aug 31, 2018
NSCLC (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemo Trial in Worldwide (OSI-906, erlotinib, )
Completed
- Non-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy
- OSI-906
- +2 more
-
Jacksonville, Florida
- +68 more
Aug 31, 2018
Colorectal Cancer Trial in Aurora (OSI-906, irinotecan)
Terminated
- Colorectal Cancer
- OSI-906
- irinotecan
-
Aurora, ColoradoUniversity of Colorado Denver
Oct 18, 2013
Hormone-sensitive Metastatic Breast Cancer Trial in Franklin, Nashville (OSI-906, Erlotinib, Letrozole)
Terminated
- Hormone-sensitive Metastatic Breast Cancer
- OSI-906
- +3 more
-
Franklin, Tennessee
- +2 more
Aug 10, 2012